Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Ophthalmic Devices Market Forecast 2014-2024


News provided by

Visiongain

09 Jun, 2014, 13:00 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, June 9, 2014 /PRNewswire/ --

Future Prospects for Leading Companies 

Ophthalmic devices - new study showing you trends, R&D progress, and predicted revenues
Where is the ophthalmic devices market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there.

Our 192-page report provides 142 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and national level. You will see financial results, interviews, trends, opportunities, and revenue predictions. Much opportunity remains in this growing medical device market.

Forecasts from 2014-2024 and other analyses show you commercial prospects
Besides revenue forecasting to 2024, our new study provides you with recent results, growth rates, and market shares. There you will find original analyses, with business outlooks and developments. Discover qualitative analyses (SWOT and Porter's Five Forces Analysis), company profiles and commercial developments. Read the full transcripts of 2 exclusive expert opinion interviews from industry specialists informing your understanding and allowing you to assess prospects for investments and sales:
- Professor Bernard Chang, Consultant Ophthalmologist, Spire Leeds Hospital
- Will Moore, CEO and President, IRIDEX

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, you see forecasts to 2024 for three submarkets and their respective segments:
• Diagnostic and monitoring
- Autorefractor/Keratometer
- OCT machines
- Fundus cameras
- Slit lamps
- Others
• Surgical
- Intraocular lenses
- Ophthalmic lasers
- Phacoemulsification devices
- Ophthalmic viscoelastic devices
- Others
• Vision care
- Daily disposables
- Others

Our investigation discusses what stimulates and restrains business. You will find dynamics of the industry and assess its potential sales, seeing devices and procedures likely to achieve the most success.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

What are the prospects in the leading regions and countries?
In addition to analyses of the overall world market, you will discover individual revenue forecasts for 13 national markets to 2024:
• US
• Japan
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Brazil
• Russia
• India
• China
• South Korea
• Mexico
• RoW

There will be growth in established medical devices markets and in developing countries. Our analyses show that India, Brazil, China, Russia and South Korea in particular, will continue to achieve high revenue growth to 2024. Developments worldwide in product approval and regulations will influence the market.

Leading companies and potential for market growth
Overall world revenue for ophthalmic devices will reach $16.29bn in 2014, our work forecasts. We predict steady revenue growth from 2014 to 2024. Rising demand for ophthalmic devices and expanding healthcare coverage in emerging economies will increase sales to 2024.

Our work shows you what organisations hold greatest potential. See profiles of 10 leading companies, including these:
• Alcon (Novartis)
• Abbott Medical Optics (Abbott)
• Bausch and Lomb (Valeant Pharmaceuticals)
• Johnson and Johnson Vision Care (Johnson and Johnson)
• Nidek
• Hoya Corporation
• STAAR Surgical
• Carl Zeiss AG Meditec
• Topcon Corporation
• Haag-Streit Holding AG

In general, a company profile gives you the following information:
• Discussion of a company's activities and outlook
• Recent financial results
• Assessment of recent developments - mergers and acquisitions (M&A), new products, and collaborations, including alliances, partnerships and joint ventures

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect the ophthalmic devices industry?
Our new report discusses issues and events affecting the ophthalmic devices market. You will find discussions, including qualitative analyses:
• A global aging population
• Increasing prevalence of eye disorders
• Increasing funds for R&D and clinical development
• Increasing sophistication of ophthalmic diagnostic devices
• Impact of the US medical device excise tax

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

How the Ophthalmic Devices Market Forecast 2014-2024: Future Prospects for Leading Companies report helps you
In summary, our 192 page report gives you the following knowledge:
• Revenues forecast to 2024 for the world ophthalmic devices market - discover the industry's prospects,
• Revenue forecasts for 3 submarkets and 12 distinctive segments finding promising places for investments and revenues
• Revenue forecasts to 2024 for the leading 13 national markets - US, Japan, Germany, France, UK, Italy, Spain, Rest of Europe, Brazil, Russia, India, China, Mexico, South Korea and RoW
• Assessment of 10 leading companies - hear about products, results and strategies including recent activities and outlook.
• Review of R&D pipelines - investigate developmental trends and progress
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
• View opinions from our survey, seeing interviews with authorities

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the ophthalmic devices market and leading companies. You find data, trends and predictions. Please order our report now.

To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44(0)20-7336-6100 Or click on https://www.visiongain.com/Report/1272/Ophthalmic-Devices-Market-Forecast-2014-2024

Companies Listed in this report: 

Aaren Scientific
Abbott Medical Optics
Acufocus
Alcon (acquired by Novartis)
Alimera Sciences
Allergan
Anew Optics
Aquesys
Bausch and Lomb (acquired by Valeant)
Bausch and Lomb Technolas
Canon
Carl Zeiss AG Meditec
CIBA Vison
CooperVision
Endure Medical Systems
Eyeonics
ForSight Vision5
Forus Health
Genentech
Glaukos
Google
Haag-Streit
Heidelberg Engineering
Hoya
HumanOptics
Implandata Ophthalmic Products GmbH
InnoCore Pharmaceuticals
InSight
Iridex
Ivantis
Johnson & Johnson Vision Care
LENSAR
LenSx Lasers
Lumenis
Mati Therapeutics
Medennium
NeoMedix Corporation
Nestlé
Neurotech Pharmaceuticals
Nidek
Novartis
NuLens
Ocular Therapeutix
OPHTEC
OptiMedica
Optovue
OSI Pharmaceuticals
PowerVision
Quest Vision
Regeneron
Retina Implant AG
Sauflon
Second Sight
SensoMotoric Instruments
STAAR Surgical
Tomey
TopCon
Transcend Medical
Triggerfish
Valeant
Vistakon (Johnson & Johnson Vision Care)
VISX

Other Organisations Mentioned in this Report
A* Star Institute for Infocomm Research
Brein Holden Vision Institute and School of Optometry and Vision Science, University of New South Wales
Center for Disease Control and Prevention (CDC) (US)
International Diabetes Federation
National Competent Authorities (NCAs) of Member States
National Institute of Statistics and Geography (INEGI) (Mexico)
The Food and Drug Administration (FDA) (US)
The Japanese Ministry of Health, Labour, and Welfare (MHLW)
The Leeds Teaching Hospitals NHS Trust
The National Institute of Clinical Excellence (NICE)
The Pharmaceutical and Medical Devices Agency (PMDA)
The US Preventive Services Task Force (USPSTF)
U.S. Center for Medicare and Medicaid Services (CMS)
United Nations (UN)
World Health Organisation (WHO)

To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.